Welcome Guest  |  Register/Login  | 
Email: sales@marketreportsonline.com Call : + 1 888 391 5441
SEARCH:   

Citigroup Inc. (C) - Medical Equipment - Advisory Profile

Published : 
No. of Pages : 431
  Buy Now  

Citigroup Inc. (C) - Medical Equipment - Advisory Profile


Summary


Citigroup Inc. (Citigroup) is a diversified financial services holding company. The company together with its subsidiaries offers a wide range of financial services to its individual customers, corporate customers, government and institution. The company’s financial products and services offering include consumer banking and credit, corporate and investment banking, securities brokerage, and wealth management, mortgage lending, consumer finance and retail banking products and services. It also provides commercial banking and cash management, trade finance and e-commerce products and services, and private banking products and services. The company serves over 200 million customers across 160 countries and jurisdiction. Citigroup categories its operations into two business segments namely, Citicorp and Citi Holdings. The company operates across North America, Europe, Middle East and Africa (EMEA), Latin America and Asia. Citigroup is headquartered in New York, the US.

The company's strategic intent is to be a digital bank offering latest technologies for enhancing and facilitating its services, for which the company has entered into an agreement with IBM to use Watson Technologies developed by IBM.


GlobalData’s Citigroup Inc. (C) - Medical Equipment - Advisory Profile provides an overview of the deals advised by Citigroup Inc. in the Medical Equipment market. The report is an essential source of information for Medical Equipment companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Citigroup Inc.'s deals for the past five years segregated into year, deal type, segment and geography.


Scope


- Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
- Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
- Analyzes the advisor’s deals by year, deal type, segment and geography
- Provides detailed information on deal particulars, including information about other advisors involved in the deal
- Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
- Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
- Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies)


Reasons to Buy

- Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
- Peruse all the advisor’s deals in the Industry market
- Access detailed information about the advisor’s financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
- Identify other potential advisors currently active in your industry, or industry that you wish to foray into
- Compare your advisory services vis-à-vis your competitors’
- Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
- Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor’s profile for your academic or business research needs and their suitability to your requirements.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 8
Citigroup Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 9
Citigroup Inc., Medical Equipment Deals Advised By Type, 2006 to YTD 2012 10
Citigroup Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 11
Citigroup Inc., Medical Equipment Deals Advised By Market, 2006 to YTD 2012 12
Citigroup Inc., Medical Equipment Deals Advised Summary, 2006 to YTD 2012 13
Citigroup Inc., Medical Equipment, Deal Details 31
Acquisition 31
Asset Transactions 63
Debt Offerings 65
Equity Offerings 364
Merger Deals 396
Private Equity 398
Venture Financing 425
Appendix 426
Methodology 426
About GlobalData 426
Contact Us 426
Disclaimer 426


List of Tables
Citigroup Inc., Key Facts 1
Citigroup Inc., Medical Equipment Deals Advised Summary, 2006 to YTD 2012 1
Citigroup Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 14
Citigroup Inc., Medical Equipment Deals Advised By Type, 2006 to YTD 2012 15
Citigroup Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 16
Citigroup Inc. Deals Advised By Market, 2006 to YTD 2012 17
Citigroup Inc., Medical Equipment Deals Advised Summary, 2006 to YTD 2012 18
Amplifon Acquires NHC Group 36
Johnson & Johnson Acquires Mentor 38
HMS Holdings Completes Acquisition Of HealthDataInsights For $400 Million 40
The Dow Chemical Company Acquires Rohm and Haas 42
Stryker Completes Acquisition Of Concentric Medical For $135 Million 44
Endo Pharma Holding Completes Acquisition Of HealthTronics 45
Flextronics International Acquires Solectron For $3,591.94 Million 47
Roche Acquires Ventana Medical Systems 49
Fisher Scientific International Acquires Athena Diagnostics From Behrman Capital 51
Roche Extends Tender Offer To Acquire Illumina For $5.7 Billion 53
Novartis Completes Acquisition Of Additional 52% Stake In Alcon From Nestle 56
Kimberly-Clark Completes Acquisition Of I-Flow 59
Stryker Completes Acquisition Of Orthovita 61
Cardiovascular Systems Acquires Replidyne 64
MedAssets Acquires Accuro Healthcare Solutions 66
Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor 68
Wyeth Completes Public Offering Of $500 Million Senior Notes 70
Eli Lilly Completes Public Offering Of 5.2% Notes For $1,000 Million 72
Royal DSM Completes Public Offering Of 5.25% Fixed Rate Notes For $966 Million 74
Becton, Dickinson and Company Completes Public Offering Of 5% Notes For $500 Million 75
Baxter International Completes Public Offering Of 4% Senior Notes For $350 Million 77
Kimberly-Clark Completes Public Offering Of Floating Rate Notes For $950 Million 78
Novartis Completes Public Offering Of 1.9% Senior Notes For $2,000 Million 79
Zimmer Holdings Completes Public Offering Of 5.75% Senior Unsecured Notes For $500 Million 81
Dupont Completes 5% Notes Offering For $750 Million 83
Eisai Issues 1.34% Three Year Bonds For $383 Million 85
Royal Philips Electronics Completes Public Offering Of 4.625% Senior Notes For $500 Million 86
Baxter International Completes Public Offering Of 6.25% Senior Notes For $500 Million 88
Johnson & Johnson Completes Public Offering Of 0.70% Senior Unsecured Notes Due 2013 For $500 Million 90
The Dow Chemical Prices Public Offering Of 2.8% Senior Unsecured Notes For $5.2 Million 92
DuPont Completes Public Offering Of Notes Due 2014 For $600 Million 93
Kimberly-Clark Completes Public Offering Of 5.3% Senior Notes Due 2041 For $450 Million 95
Becton, Dickinson and Company Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2040 For $300 Million 96
Hospira Completes Debt Offering Of Senior Notes Due 2040 For $500 Million 97
Agilent Technologies Completes Public Offering Of 2.5% Senior Notes For $250 Million 99
Zimmer Holdings Completes Public Offering Of 1.4% Senior Notes Due 2014 For $250 Million 101
DENTSPLY International Completes Public Offering Of Floating Rate Senior Notes Due 2013 For $250 Million 103
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2021 For $450 Million 105
The Dow Chemical Prices Public Offering Of 4.45% Senior Unsecured Notes For $12.3 Million 107
DuPont Completes Public Offering Of 4.25% Notes Due 2021 For $500 Million 108
Kimberly-Clark Completes Public Offering Of 3.875% Senior Notes Due 2021 For $250 Million 110
Jabil Circuit Completes Public Offering Of 5.625% Senior Notes For $400 Million 111
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For $650 Million 113
Agilent Technologies Completes Public Offering Of 5% Senior Notes For $500 Million 115
Baxter International Completes Public Offering Of 1.8% Senior Unsecured Notes For $300 Million 117
Waste Management Completes Offering Of 6.125% Senior Notes Due 2039 For $600 Million 118
Agilent Technologies Completes Public Offering Of 4.45% Senior Notes For $250 Million 120
Becton, Dickinson and Company Completes Public Offering Of 6% Notes For $250 Million 122
DuPont Issues $400 Million 4.75% Notes Due 2015 124
Bayer Completes Public Offering Of 4% Bonds For $284 Million 126
Dupont Completes 6% Notes Offering For $1.25 Billion 128
Royal Philips Electronics Completes Public Offering Of 5.75% Senior Notes For $1,250 Million 130
Honeywell Completes Public Offering Of $500 Million Floating Rate Senior Notes Due 2009 132
Honeywell International Completes Public Offering Of $400 Million 5.3% Senior Notes Due 2017 134
Bristol-Myers Completes Public Offering Of 5.875% Notes Due 2036 For $1,250 Million 136
Abbott Labs Completes Public Offering Of Notes Due 2016 For $2,000 Million 138
Honeywell Completes Public Offering Of $300 Million Floating Rate Senior Notes Due 2009 140
Bristol-Myers Completes Public Offering Of 6.125% Senior Notes For $1,000 Million 142
Royal Philips Electronics Completes Public Offering Of 6.875% Senior Notes For $1,000 Million 144
Abbott Labs Completes Public Offering Of Notes Due 2012 For $1,000 Million 146
Johnson & Johnson Completes Public Offering Of 5.15% Notes Due 2012 For $600 Million 148
Honeywell Completes Public Offering Of $400 Million 5.625% Senior Note Due 2012 150
Baxter International Completes Public Offering Of 4.25% Senior Unsecured Notes For $300 Million 152
DuPont Completes Public Offering Of 4.625% Senior Notes For $1,000 Million 153
Agilent Technologies Completes Public Offering Of 5.5% Senior Notes For $500 Million 155
Hospira Completes Public Offering Of 6.4% Notes For $250 Million 157
DuPont Issues $500 Million 5.75% Notes Due 2019 158
Bayer Completes Public Offering Of 3.575% Bonds For $170 Million 160
Zimmer Holdings Completes Public Offering Of 3.375% Senior Notes Due 2021 For $300 Million 162
DENTSPLY International Completes Public Offering Of 2.75% Senior Notes Due 2016 For $300 Million 164
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2041 For $300 Million 166
The Dow Chemical Prices Public Offering Of 3.8% Senior Unsecured Notes For $5.2 Million 168
DuPont Completes Public Offering Of 1.75% Notes Due 2014 For $400 Million 169
Life Technologies Completes Public Offering Of Senior Notes Due 2021 For $400 Million 171
MedQuist Completes Offering Of 13% Senior Subordinated Notes Due 2016 For $85 Million 173
Johnson & Johnson Completes Offering Of 2.95% Notes Due 2020 For $550 Million 174
Covidien Completes Public Offering Of 1.875% Senior Notes Due 2013 For $500 Million 176
Honeywell International Completes Public Offering Of $600 Million 5.7% Senior Notes Due 2037 178
The Cooper Companies Completes Private Placement Of $350 Million 180
Abbott Labs Completes Public Offering Of Notes Due 2011 For $1,500 Million 181
Honeywell Completes Public Offering Of $550 Million 5.7% Senior Notes Due 2036 183
DENTSPLY International Completes Public Offering Of 4.125% Senior Notes Due 2021 For $450 Million 185
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2016 For $900 Million 187
Texas Instruments Completes Public Offering Of 1.375% Notes Due 2014 For $1 Billion 189
DuPont Completes Public Offering Of 2.75% Notes Due 2016 For $500 Million 191
Life Technologies Completes Public Offering Of Senior Notes Due 2016 For $400 Million 193
Hospira Completes Public Offering Of 5.55% Notes For $500 Million 195
Abbott Labs Completes Public Offering Of 5.375% Notes For $500 Million 196
Honeywell Completes Public Offering Of $400 Million 5.4% Senior Notes Due 2016 198
Bayer Completes Public Offering Of Floating Rate Bonds For $94.11 Million 200
Bristol-Myers Completes Public Offering Of 5.45% Senior Notes For $600 Million 202
Royal Philips Electronics Completes Public Offering Of Floating Rate Senior Notes For $350 Million 204
Abbott Labs Completes Public Offering Of Notes Due 2037 For $1,000 Million 205
Johnson & Johnson Completes Public Offering Of 5.95% Notes Due 2037 For $1,000 Million 207
Kimberly-Clark Completes Public Offering Of Floating Rate Notes For $700 Million 209
Johnson & Johnson Completes Offering Of 4.5% Notes Due 2040 For $550 Million 210
Covidien Completes Public Offering Of 2.8% Senior Notes Due 2015 For $400 Million 212
Medtronic Completes Public Offering Of 3% Senior Notes For $1,250 Million 214
NIPRO Completes Private Placement Of Bonds Due 2015 For $165.56 Million 216
DuPont Completes Public Offering Of 3.25% Senior Notes For $1,000 Million 217
Baxter International Completes Public Offering Of 4.5% Senior Notes For $500 Million 219
Eli Lilly Completes Public Offering Of 3.55% Notes For $1,000 Million 220
Honeywell International Completes Public Offering Of $900 Million 5% Senior Notes Due 2019 221
Honeywell International Completes Public Offering Of 5.3% Senior Notes For $900 Million 223
Abbott Labs Completes Public Offering Of Notes Due 2017 For $1,500 Million 225
Johnson & Johnson Completes Public Offering Of 5.55% Notes Due 2017 For $1,000 Million 227
Bayer Completes Public Offering Of 1.585% Bonds For $81.48 Million 229
Bayer Completes Public Offering Of Floating Rate Bonds For $401 Million 231
Hospira Completes Public Offering Of Floating Rate Notes For $375 Million 233
Dupont Completes 5.25% Notes Offering For $600 Million 234
Corning Completes Public Offering Of 7.25% Notes For $250 Million 235
Allergan Completes Private Placement Of $800 Million 236
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2013 For $500 Million 237
Texas Instruments Completes Public Offering Of Floating Rate Notes Due 2013 For $1 Billion 239
Medtronic Completes Public Offering Of Senior Notes Due 2016 For $500 Million 241
Eastman Chemical Completes Offering Of 4.5% Senior Notes Due 2021 For $250 Million 242
DuPont Completes Public Offering Of 4.9% Senior Notes Due 2041 For $500 Million 244
Corning Completes Public Offering Of 5.75% Senior Unsecured Notes For $400 Million 246
Covidien Completes Public Offering Of 4.2%Senior Notes Due 2020 For $600 Million 247
Medtronic Completes Public Offering Of 5.55% Senior Notes For $500 Million 249
Stryker Completes Public Offering Of 3% Senior Unsecured Notes For $500 Million 251
Jabil Circuit Completes Public Offering Of 7.75% Senior Notes For $312 Million 253
Eli Lilly Completes Public Offering Of 4.2% Notes For $1,000 Million 255
Honeywell International Completes Public Offering Of $600 Million 3.88% Senior Notes Due 2019 256
Royal DSM Completes Public Offering Of 5.75% Fixed Rate Notes For $646 Million 258
Luxottica Group Prices Public Offering Of Bond Due 2019 For $656 Million 259
Becton, Dickinson Completes Public Offering Of Notes Due 2021 For $1 Billion 260
Kimberly-Clark Prices Public Offering Of Senior Notes Due 2022 For $300 Million 262
Becton, Dickinson Completes Public Offering Of Notes Due 2016 For $500 Million 263
Allergan Completes Private Placement Of $750 Million 265
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For $1,000 Million 266
Medtronic Completes Public Offering Of Senior Notes Due 2021 For $500 Million 268
Eastman Chemical Completes Offering Of 3% Senior Notes Due 2015 For $250 Million 269
DuPont Completes Public Offering Of 1.95% Senior Notes Due 2016 For $500 Million 271
Corning Completes Public Offering Of 4.25% Senior Unsecured Notes For $300 Million 273
Abbott Labs Completes Public Offering Of 2.7% Notes For $750 Million 274
Medtronic Completes Public Offering Of 4.45% Senior Notes For $1,250 Million 276
Stryker Completes Public Offering Of 4.375% Senior Unsecured Notes For $500 Million 278
Eastman Completes Offering Of 5.5% Notes Due 2019 For $250 Million 280
Air Liquide Completes Bond Issue Of $560 Million 282
Eli Lilly Completes Public Offering Of 5.95% Notes For $400 Million 283
Novartis Completes Public Offering Of 4.125% Bonds For $2,000 Million 284
Honeywell International Completes Public Offering Of 4.25% Senior Notes For $600 Million 286
Johnson & Johnson Completes Public Offering Of 4.75% Notes Due 2019 For $1,500 Million 288
Fujitsu Completes Private Placement Of Convertible Bonds For $846.8 Million 290
Bayer Completes Public Offering Of 1.955% Bonds For $122.23 Million 291
Bayer Completes Public Offering Of Fixed Rate Bonds For $267 Million 293
Hospira Completes Public Offering Of 6.05% Notes For $550 Million 295
DuPont Completes 5.6% Notes Offering For $400 Million 296
Beckman Coulter Completes Public Offering Of 7% Senior Notes For $250 Million 297
Abbott Labs Completes Public Offering Of 5.125% Notes For $2,000 Million 298
Novartis Completes Public Offering Of 5.125% Bonds For $3,000 Million 300
Kimberly-Clark Completes Public Offering Of 7.5% Notes For $500 Million 302
Perkinelmer Completes Private Placement Of Series 2008-A Senior Notes Due 2015 For $150 Million 303
Johnson & Johnson Completes Public Offering Of Notes Due 2038 For $700 Million 304
Ecolab Completes Public Offering Of Senior Unsecured Notes For $250 Million 306
Johnson & Johnson Completes Public Offering Of 5.5% Notes Due 2024 For $1,000 Million 308



List of Figures
Citigroup Inc., Medical Equipment Deals Advised by Deal Type, 2006 to YTD 2012 1
Citigroup Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 1
Citigroup Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 1
Citigroup Inc., Medical Equipment Deals Advised By Market, 2006 to YTD 2012 1
Citigroup Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 14
Citigroup Inc., Medical Equipment Deals Advised by Deal Type, 2006 to YTD 2012 15
Citigroup Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 16
Citigroup Inc., Medical Equipment Deals Advised by Market, 2006 to YTD 2012 17

Citigroup Inc. (C) - Medical Equipment - Advisory Profile

Published By: GlobalData
 

How to Purchase


Purchase products from our site in 5 easy steps.  Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .


Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option
Get Email alerts about market research reports from industries and publishers of your interest:
© 2009 Market Research Reports. All Rights Reserved. Privacy Policy. Terms & Conditions